Finance

Lists
NHI:NYSE
National Health Investors Inc
USD 65,67
+0,47%
(+0,31) 1D
USD 65,67
0,00% (0,00)
After hours
Closed: 15 Okt., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NHI...
Open
USD 66,49
High
USD 67,18
Low
USD 65,64
Mkt. cap
3,23 mjd
Avg. vol.
381,11 k
Volume
0,00
Dividend
5,63%
Quarterly dividend
USD 0,93
Ex-dividend date
30 Sep. 2026
P/E ratio
19,01
52-wk high
USD 91,38
52-wk low
USD 63,51
EPS
USD 3,46
Beta
0,49
Shares outstanding
49,11 m
No. of employees
32
Open
USD 66,49
High
USD 67,18
Low
USD 65,64
Mkt. cap
3,23 mjd
Avg. vol.
381,11 k
Volume
0,00
Dividend
5,63%
Quarterly dividend
USD 0,93
Ex-dividend date
30 Sep. 2026
P/E ratio
19,01
52-wk high
USD 91,38
52-wk low
USD 63,51
EPS
USD 3,46
Beta
0,49
Shares outstanding
49,11 m
No. of employees
32
News stories
From web sources and news partners
About National Health Investors Inc
CEO-
Employees32
Founded1991
HeadquartersMurfreesboro, Tennessee, Verenigde State van Amerika
SectorReal estate investment trust
Websitenhireit.com
Analyst ratings
Based on 6 analysts giving stock ratings to NHI in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for NHI in the last 3 months.
Highest
Current USD 65,67
USD 90,00 (+37,05%)
Average
USD 82,17 (+25,13%)
Lowest
USD 78,00 (+18,78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Juan C. Sanabria
BMO Capital
Buy
Maintained
USD 80,00
+21,8%
10/05/2026
Robert Stevenson
Janney Montgomery
Buy
Initiated
USD 79,00
+20,3%
09/09/2026
Michael Lewis
Truist Financial
Buy
Maintained
USD 80,00
+21,8%
09/02/2026
John Kilichowski
Wells Fargo
Hold
Reiterated
USD 78,00
+18,8%
09/01/2026
Farrell Granath
Bank of America Securities
Buy
Maintained
USD 86,00
+31%
08/24/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
USD 90,00
+37%
08/14/2026
Omotayo Okusanya
Deutsche Bank
Hold
Maintained
USD 80,00
+21,8%
06/25/2026
Last report
11 Aug. 2026
Fiscal period
Q2 2026
USD 1,15 / USD 4,57
-74,82%miss
Revenue / Est. (USD)
121,32 m / 112,51 m
+7,83%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
89,92 m
107,48 m
115,13 m
121,32 m
Cost of goods sold
18,86 m
26,00 m
30,92 m
36,44 m
Cost of revenue
18,86 m
26,00 m
30,92 m
36,44 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,44 m
7,61 m
8,16 m
9,27 m
Operating expense
26,90 m
29,59 m
32,06 m
35,03 m
Total operating expenses
45,77 m
55,59 m
62,98 m
71,47 m
Operating income
44,15 m
51,89 m
52,14 m
49,85 m
Other non operating income
-
-
35,00 k
86,00 k
EBT including unusual items
32,48 m
37,80 m
39,75 m
56,09 m
EBT excluding unusual items
30,39 m
37,62 m
37,14 m
34,12 m
Income tax expense
-
-
-
732,00 k
Effective tax rate
-
-
-
1,30%
Other operating expenses
244,00 k
324,00 k
215,00 k
213,00 k
Net income
32,86 m
38,16 m
40,10 m
55,67 m
Net profit margin
36,55%
35,51%
34,83%
45,89%
Earnings per share
0,69
0,76
0,77
1,15
Interest and investment income
-
-
-
-
Interest expense
-13,77 m
-14,26 m
-15,04 m
-15,81 m
Net interest expenses
-13,77 m
-14,26 m
-15,04 m
-15,81 m
Depreciation and amortization charges
20,22 m
21,65 m
23,69 m
25,55 m
EBITDA
64,37 m
73,54 m
75,84 m
75,40 m
Gain or loss from assets sale
-113,00 k
-119,00 k
-2,61 m
-21,97 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme